Mai Capital Management Pfizer Inc Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

A detailed history of Mai Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Mai Capital Management holds 697,658 shares of PFE stock, worth $19.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

697,658

Previous 686,277 1.66%

Holding current value

$19.2 Million

Previous $19.2 Million 5.15%

% of portfolio

0.2%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$27.7 - $31.39 $315,253 - $357,249	11,381 Added 1.66%	697,658 $20.2 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $646,984 - $758,144	-25,613 Reduced 3.6%	686,277 $19.2 Million
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $1.94 Million - $2.23 Million	74,983 Added 11.77%	711,890 $19.8 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $8.82 Million - $11.5 Million	337,538 Added 112.75%	636,907 $18.3 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $360,178 - $421,012	-11,224 Reduced 3.61%	299,369 $9.93 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $471,510 - $545,526	-13,054 Reduced 4.03%	310,593 $11.4 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $492,256 - $640,846	-12,497 Reduced 3.72%	323,647 $13.2 Million
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $652,135 - $851,290	15,620 Added 4.87%	336,144 $17.2 Million
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $2.33 Million - $2.85 Million	53,338 Added 19.96%	320,524 $14 Million
Q2 2022 Jul 19, 2022	BUY	$46.53 - $55.17 $895,469 - $1.06 Million	19,245 Added 7.76%	267,186 $14 Million
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $22,737 - $28,174	497 Added 0.2%	247,941 $12.8 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $1.74 Million - $2.58 Million	42,080 Added 20.49%	247,444 $14.6 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $7,693 - $9,882	-196 Reduced 0.1%	205,364 $8.83 Million
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $120,585 - $136,603	3,358 Added 1.66%	205,560 $8.05 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $584,065 - $658,708	17,440 Added 9.44%	202,202 $7.33 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $823,194 - $1.05 Million	24,595 Added 15.36%	184,762 $6.8 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $51,943 - $60,941	-1,636 Reduced 1.01%	160,167 $5.88 Million
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $161,533 - $195,964	5,363 Added 3.43%	161,803 $5.29 Million
Q1 2020 Apr 16, 2020	BUY	$27.03 - $38.62 $79,089 - $113,002	2,926 Added 1.91%	156,440 $5.11 Million
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $2 Million - $2.27 Million	60,720 Added 65.44%	153,514 $6.02 Million
Q3 2019 Oct 29, 2019	SELL	$32.49 - $42.13 $416,326 - $539,853	-12,814 Reduced 12.13%	92,794 $3.33 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $441,578 - $495,790	11,941 Added 12.75%	105,608 $4.58 Million
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $218,812 - $240,402	-5,835 Reduced 5.86%	93,667 $3.98 Million
Q4 2018 Jan 30, 2019	BUY	$38.47 - $43.86 $141,800 - $161,667	3,686 Added 3.85%	99,502 $4.34 Million
Q3 2018 Oct 12, 2018	SELL	$34.47 - $41.81 $347,940 - $422,030	-10,094 Reduced 9.53%	95,816 $4.22 Million
Q2 2018 Aug 16, 2018	BUY	$32.98 - $35.16 $74,139 - $79,039	2,248 Added 2.17%	105,910 $3.84 Million
Q1 2018 Apr 17, 2018	BUY	$31.91 - $37.02 $191,779 - $222,490	6,010 Added 6.15%	103,662 $3.68 Million
Q4 2017 Jan 30, 2018	SELL	$33.26 - $35.29 $604,433 - $641,325	-18,173 Reduced 15.69%	97,652 $3.54 Million
Q3 2017 Oct 12, 2017	SELL	$31.0 - $34.15 $1,736 - $1,912	-56 Reduced 0.05%	115,825 $4.14 Million
Q2 2017 Aug 07, 2017	BUY	N/A	115,881	115,881 $3.89 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Pfizer Inc Transaction History